Impaired factor XIII activation in patients with congenital afibrinogenemia

• Françoise Bridey,
• Claude Négrier,
• Cedric Duval,
• Robert Ariëns,
• Philippe de Moerloose,
• Alessandro Casini

Affiliations

Françoise Bridey

Clinical Development, Laboratoire Français du Fractionnement et des Biotechnologies (LFB), Les Ulis, France

Claude Négrier

Hemostasis Unit, Hematology Division, Louis Pradel University Hospital, University Claude Bernard, Lyon, France

Cedric Duval

Thrombosis and Tissue Repair Group, Department of Discovery and Translational Science, Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, UK

Robert Ariëns

Thrombosis and Tissue Repair Group, Department of Discovery and Translational Science, Leeds Institute of Cardiovascular and Metabolic Medicine, Faculty of Medicine and Health, University of Leeds, UK

Philippe de Moerloose

Faculty of Medicine, University Hospitals of Geneva, Switzerland

Alessandro Casini

Division of Angiology and Haemostasis, Faculty of Medicine, University Hospitals of Geneva, Switzerland